Results 211 to 220 of about 2,009,855 (385)

Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences [PDF]

, 1984
Julian Downward, Yosef Yarden, E. L. V. Mayes, Geoffrey Scrace, Nicholas F. Totty, Peter A. Stockwell, A. Ullrich, Joseph Schlessinger, Michael D. Waterfield   +8 more
openalex   +1 more source

Escape from TGF‐β‐induced senescence promotes aggressive hallmarks in epithelial hepatocellular carcinoma cells

Molecular Oncology, EarlyView.
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu, Dilara Demirci, Sude Eris, Bengisu Dayanc, Ece Cakiroglu, Merve Basol, Merve Uysal, Gulcin Cakan‐Akdogan, Fang Liu, Mehmet Ozturk, Gökhan Karakülah, Serif Senturk   +11 more
wiley   +1 more source

Epidermal growth factor receptors

Journal of British Surgery, 1985
A P Savage, T Cooke, R Sainsbury, J Farndon, A Harris   +4 more
openaire   +3 more sources

Growth factor receptor plasticity drives therapeutic persistence of metastatic breast cancer. [PDF]

Cell Death Dis
Ayers M, Monteiro M, Kulkarni A, Reeser JW, Dykhuizen E, Roychowdhury S, Wendt MK.   +6 more
europepmc   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

, 1984
Alonzo H. Ross, Peter M. Grob, Mark Bothwell, D Elder, Carolyn S. Ernst, Nadia Marano, B.F.D. Ghrist, C.C. Slemp, Meenhard Herlyn, Barbara Atkinson   +9 more
openalex   +1 more source

Correction: Exploring the role of epidermal growth factor receptor variant III in meningeal tumors. [PDF]

PLoS One
Rana R, Rathi V, Chauhan K, Jain K, Chhabra SS, Acharya R, Kalra SK, Gupta A, Jain S, Ganguly NK, Yadav DK.   +10 more
europepmc   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain.

, 1987
C.R. Buck, Humberto Martínez, Ira B. Black, Moses V. Chao   +3 more
openalex   +1 more source

Urolithins' interaction with hepatocyte growth factor receptor: a mechanistic basis for anticancer activity in gastric adenocarcinoma cells. [PDF]

Discov Oncol
Hosseini F, Ahmadi A, Nasiri Sarvi Z, Iranshahy M, Rassouli FB.   +4 more
europepmc   +1 more source